Suggest that the full Kaplan-Meier PFS curves, show that at most time points separation between regorafenib and placebo is greater and the median PFS is just not representative of the the overall shape of the curves, and the hazard ratio is more indicative of the benefit of the drug.
News 
Market Data 
Discover 
